Beyond performing a chest CT, measurement of autoantibodies against BPIFB1 and KCNRG is a valuable diagnostic tool and should be considered as a screening modality in patients with thymoma and radiographic evidence of lung disease and/or chronic respiratory symptoms. Here, BPIFB1 is linked to lung disorder.